AdvanCell Isotopes Pty Ltd

0 followers

‌

AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Industries

Biotechnology, Clinical Trials

Employees

11-50

Links

Org chart

Andrew Adamovich

Chief Executive Officer

Andrew Adamovich

Collapse

Julian F. Kelly

Chief Scientist (Nuclear & Chemical)

Kevin Kuan

SVP Technical Operations

Nicolò Canever

Materials Development Manager

Sheridan Martin

Facilities Manager And Head Radiation Safety Officer

Simon Puttick

CSO/COO

Thomas Kryza

Head Of Preclinical Development

Vanessa Worsfold

Head Of Quality And Head Of Marketing

Sheruna Naidoo

Head Of Quality And Regulatory Affairs

Michael Tung

Chief Financial Officer

Teams

Research and Development

8 members

Leadership Team

4 members

Similar companies

Lundbeck

33 followers

Charlie Health

5 followers

Gameto

4 followers

Synthekine

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Immunome

2 followers

Vera Therapeutics

2 followers

Roche

245 followers

AbbVie

178 followers

Grifols

22 followers

Explore companies